Rbvoc-DSR

Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Diagnostics Innovation Biotech Environment Testing Research Diagnostics Innovation Biotech
Pantalis 40 Injection VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC CEFOTEM-1.5 INJ CEFTRALIS INJ
VOCLAV 625 Rbvoc-DSR Rabeprazole Listuss - Syrup Vocalis SP Pantalis-D Listus-AM DIVOC VOCLAV 625 Azivoc-500 tab Rbvoc-DSR Rabeprazole

Explore Our Prodcuts

Rbvoc-DSR provides fast and sustained relief for patients suffering from acid reflux, GERD (Gastroesophageal Reflux Disease), gastritis, and functional dyspepsia with nausea or bloating. Formulated with a dual combination of Rabeprazole (20 mg) and Domperidone SR (30 mg), it works by suppressing excess stomach acid and enhancing gastric motility, ensuring effective symptom control and improved digestive comfort.

It is highly effective in the treatment of erosive esophagitis, functional dyspepsia, gastritis, and acid reflux-related nausea and vomiting. Its sustained-release formulation ensures long-lasting results, better compliance, and enhanced patient outcomes.

Backed by clinical data, Rbvoc-DSR shows a high success rate in relieving GERD symptoms, healing mucosal damage, and preventing recurrence, making it a safe and trusted therapy for both acute and chronic cases.

Research & Clinical Data for Rbvoc-DSR

Indications Supported by Evidence

  • GERD & Acid Reflux: Demonstrated rapid acid suppression, mucosal healing, and improved patient comfort.
  • Functional Dyspepsia: Shown to improve gastric emptying, reduce bloating, and relieve upper abdominal discomfort.
  • Erosive Esophagitis: Proven to accelerate epithelial healing and prevent recurrence of symptoms.